Impaired Gastric Myoelectrical Activity in Patients with Parkinson's Disease and Effect of Levodopa Treatment

被引:0
|
作者
Ching-Liang Lu
Din-E Shan
Chih-Yen Chen
Jiing-Chyuan Luo
Full-Young Chang
Shou-Dong Lee
Han-Chang Wu
J. D. Z. Chen
机构
[1] Taipei Veterans General Hospital and National Yang-Ming University,Division of Gastroenterology and Neurology Department
[2] National Taiwan University,Department of Electrical Engineering
[3] University of Texas Medical Branch,Department of Internal Medicine, Division of Gastroenterology
来源
Digestive Diseases and Sciences | 2004年 / 49卷
关键词
parkinsonism; levodopa; gastric myoelectrical activity; gastric motility;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to evaluate gastric myoelectrical activity in patients with Parkinson's disease during and after levodopa treatment. Thirteen Parkinson's patients and 13 age-matched Parkinson's-free controls were enrolled. Electrogastrography was used to record gastric myoelectrical activity in all subjects for 30 min before and 30 min after a standard meal. In the group with Parkinson's disease, gastric myoelectrical activity was recorded during both the “on” (with levodopa treatment) and the “wearing-off” (without levodopa for at least 12 hr) periods. Results were as follows. (1) The patients without treatment showed a significantly lower percentage of regular slow waves and a significantly higher instability coefficient of the dominant frequency; (2) the patients showed an absence of the normal postprandial increase in gastric slow wave frequency which was seen in the controls; and (3) treatment with levodopa resulted in an improvement in the fed state, including a marginal increase in the percentage of regular slow waves (P=0.1), a significant decrease in the instability coefficient, and an enhanced postprandial power increase. In conclusion, patients with Parkinson's disease have reduced slow wave rhythmicity and an impaired postprandial response in gastric myoelectrical activity. These abnormalities may be partially corrected with levodopa treatment in the fed state.
引用
收藏
页码:744 / 749
页数:5
相关论文
共 50 条
  • [41] Levodopa delivery systems for the treatment of Parkinson's disease: An overview
    Goole, J.
    Amighi, K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 380 (1-2) : 1 - 15
  • [42] Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease
    Yokochi, Masayuki
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S25 - S30
  • [43] The effects of Nardosinone on levodopa intervention in the treatment of Parkinson's disease
    Liu, Mengmeng
    Xue, Jingwen
    Cao, Yuxin
    Hao, Zhuangzhuang
    Wang, Yuqing
    Li, Jiayuan
    Jiang, Tingyue
    Shi, Jinli
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 174
  • [44] Parkinson’s disease: Initial treatment with levodopa or dopamine agonists
    Stewart A. Factor
    Current Treatment Options in Neurology, 2001, 3 (6) : 479 - 493
  • [45] The initial treatment of Parkinson's disease should begin with levodopa
    Weiner, WJ
    MOVEMENT DISORDERS, 1999, 14 (05) : 716 - 724
  • [46] Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease
    Palacios, Natalia
    Hannoun, Anas
    Flahive, Julie
    Ward, Doyle
    Goostrey, Kelsey
    Deb, Anindita
    Smith, Kara M.
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [47] For better or worse: The effect of levodopa on speech in Parkinson's disease
    Ho, Aileen K.
    Bradshaw, John L.
    Iansek, Robert
    MOVEMENT DISORDERS, 2008, 23 (04) : 574 - 580
  • [48] Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson's Disease
    Park, Kye Won
    Jo, Sungyang
    Lee, Seung Hyun
    Hwang, Yun Su
    Lee, Dagyo
    Ryu, Ho-Sung
    Chung, Sun Ju
    JOURNAL OF MOVEMENT DISORDERS, 2020, 13 (03) : 205 - 212
  • [49] Exercise improves efficacy of levodopa in patients with Parkinson's disease
    Muhlack, Siegfried
    Welnic, Jacub
    Woitalla, Dirk
    Mueller, Thomas
    MOVEMENT DISORDERS, 2007, 22 (03) : 427 - 430
  • [50] Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease
    Muhlack, S
    Woitalla, D
    Welnic, J
    Twiehaus, S
    Przuntek, H
    Müller, T
    NEUROSCIENCE LETTERS, 2004, 363 (03) : 284 - 287